<DOC>
	<DOCNO>NCT01333098</DOCNO>
	<brief_summary>This study seek develop test novel , mechanistic treatment mitigate cognitive impairment older adult anxiety disorder . Anxiety disorder common , severe , disable old adult . One particularly impairing aspect late-life anxiety disorder cognitive impairment : impairment memory executive function cause disability , impede treatment response psychotherapy , may lead dementia , correct standard anti-anxiety treatment . This pilot study test glucocorticoid antagonist , mifepristone , cognitive impairment late-life anxiety disorder . Mifepristone block effect elevate cortisol level glucocorticoid receptor brain ; study preliminarily various neuropsychiatric disorder , psychotic depression bipolar disorder , well-documented safety tolerability .</brief_summary>
	<brief_title>Antiglucocorticoid Therapy Cognitive Impairment Late-life Anxiety Disorders</brief_title>
	<detailed_description>Currently , treatment exists address cognitive impairment late-life anxiety disorder . In study , fifteen patient age 60+ anxiety disorder ( current partial remission ) subjective and/or objective evidence cognitive impairment receive treatment mifepristone . At baseline visit participant randomize receive either mifepristone 300mg placebo daily 7 day . Participants reassess 7 day ( week 1 visit ) receive study medication ( mifepristone placebo ) . At time participant provide mifepristone 300mg daily remain 3 week study treatment . The primary outcome measure neurocognition , assess battery neuropsychological measure focus immediate delayed memory executive function ( administered baseline , week 1 , week 4 , week 12 ) . Saliva sample cortisol measurement collect immediately follow baseline visit week 4 visit . Secondary outcome self-reported anxiety depressive symptom .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>Age 65 older Nondemented clinical evaluation Current partially remit generalized anxiety disorder panic disorder Currently take antidepressant treatment stable dose least 8 week Memory impairment Mild severe dementia Diabetes Current alcohol substance abuse Current lifetime psychotic symptom , bipolar disorder , eat disorder Untreated endocrinologic disease Lifetime Cushing 's Addison 's disease Current cancer History metastatic cancer Current use systemic corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>anxiety</keyword>
	<keyword>old adult</keyword>
	<keyword>memory</keyword>
	<keyword>cognitive</keyword>
	<keyword>Saint Louis</keyword>
	<keyword>treatment</keyword>
	<keyword>Non-dementia cognitive impairment older adult anxiety disorder .</keyword>
</DOC>